Skip Navigation

A Phase IB and Randomized Open-Label Phase II Study of Berzosertib M6620, VX-970 in Combination with Carboplatin/Gemcitabine/Pembrolizumab in Patients with Chemotherapy-Na ve Advanced Non-Small Cell Lung Cancer of Squamous Cell Histology

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT04216316

Study #:
STUDY00146150

Start Date:
Sep 24, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04216316

View Complete Trial Details & Eligibility at ClinicalTrials.gov